These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 27225840

  • 1. External Validation of the Hestia Criteria for Identifying Acute Pulmonary Embolism Patients at Low Risk of Early Mortality.
    Weeda ER, Kohn CG, Peacock WF, Fermann GJ, Crivera C, Schein JR, Coleman CI.
    Clin Appl Thromb Hemost; 2017 Oct; 23(7):769-774. PubMed ID: 27225840
    [Abstract] [Full Text] [Related]

  • 2. External validation of three risk stratification rules in patients presenting with pulmonary embolism and cancer.
    Weeda ER, Caranfa JT, Lyman GH, Kuderer NM, Nguyen E, Coleman CI, Kohn CG.
    Support Care Cancer; 2019 Mar; 27(3):921-925. PubMed ID: 30090992
    [Abstract] [Full Text] [Related]

  • 3. Accuracy and Interobserver Reliability of the Simplified Pulmonary Embolism Severity Index Versus the Hestia Criteria for Patients With Pulmonary Embolism.
    Quezada CA, Bikdeli B, Villén T, Barrios D, Mercedes E, León F, Chiluiza D, Barbero E, Yusen RD, Jimenez D.
    Acad Emerg Med; 2019 Apr; 26(4):394-401. PubMed ID: 30155937
    [Abstract] [Full Text] [Related]

  • 4. Comparison of two methods for selection of out of hospital treatment in patients with acute pulmonary embolism.
    Zondag W, den Exter PL, Crobach MJ, Dolsma A, Donker ML, Eijsvogel M, Faber LM, Hofstee HM, Kaasjager KA, Kruip MJ, Labots G, Melissant CF, Sikkens MS, Huisman MV, Hestia Study Investigators.
    Thromb Haemost; 2013 Jan; 109(1):47-52. PubMed ID: 23138355
    [Abstract] [Full Text] [Related]

  • 5. External validation of prognostic rules for early post-pulmonary embolism mortality: assessment of a claims-based and three clinical-based approaches.
    Weeda ER, Kohn CG, Fermann GJ, Peacock WF, Tanner C, McGrath D, Crivera C, Schein JR, Coleman CI.
    Thromb J; 2016 Jan; 14():7. PubMed ID: 26977136
    [Abstract] [Full Text] [Related]

  • 6. External Validation of Generic and Cancer-Specific Risk Stratification Tools in Patients With Pulmonary Embolism and Active Cancer.
    Weeda ER, Caranfa JT, Zeichner SB, Coleman CI, Nguyen E, Kohn CG.
    J Natl Compr Canc Netw; 2017 Dec; 15(12):1476-1482. PubMed ID: 29223985
    [Abstract] [Full Text] [Related]

  • 7. External validation of a claims-based and clinical approach for predicting post-pulmonary embolism outcomes among United States veterans.
    Kohn CG, Weeda ER, Kumar N, Wells PS, Peacock WF, Fermann GJ, Wang L, Baser O, Schein JR, Crivera C, Coleman CI.
    Intern Emerg Med; 2017 Aug; 12(5):613-619. PubMed ID: 28185131
    [Abstract] [Full Text] [Related]

  • 8. Risk stratifying emergency department patients with acute pulmonary embolism: Does the simplified Pulmonary Embolism Severity Index perform as well as the original?
    Vinson DR, Ballard DW, Mark DG, Huang J, Reed ME, Rauchwerger AS, Wang DH, Lin JS, Kene MV, Pleshakov TS, Sax DK, Sax JM, McLachlan DI, Yamin CK, Swap CJ, Iskin HR, Vemula R, Fleming BS, Elms AR, Aujesky D, MAPLE investigators of the KP CREST Network.
    Thromb Res; 2016 Dec; 148():1-8. PubMed ID: 27764729
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and Safety of Outpatient Treatment Based on the Hestia Clinical Decision Rule with or without N-Terminal Pro-Brain Natriuretic Peptide Testing in Patients with Acute Pulmonary Embolism. A Randomized Clinical Trial.
    den Exter PL, Zondag W, Klok FA, Brouwer RE, Dolsma J, Eijsvogel M, Faber LM, van Gerwen M, Grootenboers MJ, Heller-Baan R, Hovens MM, Jonkers GJ, van Kralingen KW, Melissant CF, Peltenburg H, Post JP, van de Ree MA, Vlasveld LT, de Vreede MJ, Huisman MV, Vesta Study Investigators *.
    Am J Respir Crit Care Med; 2016 Oct 15; 194(8):998-1006. PubMed ID: 27030891
    [Abstract] [Full Text] [Related]

  • 10. External validation of a multivariable claims-based rule for predicting in-hospital mortality and 30-day post-pulmonary embolism complications.
    Coleman CI, Peacock WF, Fermann GJ, Crivera C, Weeda ER, Hull M, DuCharme M, Becker L, Schein JR.
    BMC Health Serv Res; 2016 Oct 22; 16(1):610. PubMed ID: 27770814
    [Abstract] [Full Text] [Related]

  • 11. Rivaroxaban versus Heparin Bridging to Warfarin Therapy: Impact on Hospital Length of Stay and Treatment Costs for Low-Risk Patients with Pulmonary Embolism.
    Weeda ER, Kohn CG, Peacock WF, Fermann GJ, Crivera C, Schein JR, Coleman CI.
    Pharmacotherapy; 2016 Oct 22; 36(10):1109-1115. PubMed ID: 27548074
    [Abstract] [Full Text] [Related]

  • 12. Comparison of Different Clinical Prognostic Scores in Patients with Pulmonary Embolism and Active Cancer.
    Li X, Hu Y, Lin P, Zhang J, Tang Y, Yi Q, Liang Z, Zhou H, Wang M.
    Thromb Haemost; 2021 Jun 22; 121(6):834-844. PubMed ID: 33450779
    [Abstract] [Full Text] [Related]

  • 13. The Accuracy of Hestia and Simplified PESI to Predict the Prognosis in Pulmonary Embolism: Systematic Review with Meta-analysis.
    Palas M, Silva BV, Jorge C, Almeida AG, Pinto FJ, Caldeira D.
    TH Open; 2022 Oct 22; 6(4):e347-e353. PubMed ID: 36452203
    [Abstract] [Full Text] [Related]

  • 14. Hestia criteria can discriminate high- from low-risk patients with pulmonary embolism.
    Zondag W, Hiddinga BI, Crobach MJ, Labots G, Dolsma A, Durian M, Faber LM, Hofstee HM, Melissant CF, Ullmann EF, Vingerhoets LM, de Vreede MJ, Huisman MV, Hestia Study Investigators.
    Eur Respir J; 2013 Mar 22; 41(3):588-92. PubMed ID: 22790909
    [Abstract] [Full Text] [Related]

  • 15. The values of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in predicting 30 day mortality in patients with acute pulmonary embolism.
    Ma Y, Mao Y, He X, Sun Y, Huang S, Qiu J.
    BMC Cardiovasc Disord; 2016 Jun 04; 16():123. PubMed ID: 27259553
    [Abstract] [Full Text] [Related]

  • 16. Comparing the pulmonary embolism severity index and the prognosis in pulmonary embolism scores as risk stratification tools.
    Chan CM, Woods CJ, Shorr AF.
    J Hosp Med; 2012 Jan 04; 7(1):22-7. PubMed ID: 22042764
    [Abstract] [Full Text] [Related]

  • 17. Prognostic Performance of Hestia Criteria in Acute Pulmonary Embolism: A Systematic Review and Meta-Analysis.
    Wang Y, Feng Y, Du R, Yang X, Huang J, Mao H.
    Clin Appl Thromb Hemost; 2022 Jan 04; 28():10760296221126173. PubMed ID: 36128845
    [Abstract] [Full Text] [Related]

  • 18. Clinical prediction rules for mortality in patients with pulmonary embolism and cancer to guide outpatient management: a meta-analysis.
    Nguyen E, Caranfa JT, Lyman GH, Kuderer NM, Stirbis C, Wysocki M, Coleman CI, Weeda ER, Kohn CG.
    J Thromb Haemost; 2018 Feb 04; 16(2):279-292. PubMed ID: 29215781
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Validation of the multivariable In-hospital Mortality for PulmonAry embolism using Claims daTa (IMPACT) prediction rule within an all-payer inpatient administrative claims database.
    Coleman CI, Kohn CG, Crivera C, Schein JR, Peacock WF.
    BMJ Open; 2015 Oct 28; 5(10):e009251. PubMed ID: 26510731
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.